Contact· self-published, not guessed
Experience
- F-Prime CapitalPartnercurrent2014 — presentLondon Area, United Kingdom
- ImmutrinBoard Directorcurrent2026 — presentCambridge, England, United Kingdom
- T-Therapeutics LtdBoard Directorcurrent2023 — presentCambridge, England, United Kingdom
- CHARM TherapeuticsBoard Director, Founding Investorcurrent2021 — present
- EnsomaBoard Directorcurrent2023 — presentBoston, Massachusetts, United States
- AviadoBioBoard Directorcurrent2020 — presentGreater London, England, United Kingdom
- Orchard TherapeuticsFounding Team2016 — 2019London Area, United Kingdom
- Fidelity BiosciencesAnalyst2013 — 2014
- The Boston Consulting GroupManagement Consultant2012 — 2013London Area, United Kingdom
- OXFORD UNIVERSITY HOSPITALS NHS TRUSTAcademic Clinical Fellow2010 — 2012Oxford, United Kingdom
- University of CambridgeNeuroscience Supervisor2005 — 2012
- NHSDoctor2008 — 2012
- University College London Hospitals NHS Foundation TrustAcademic Foundation Programme in Neurology2008 — 2010
Skills & more
Venture Capital49Healthcare62Life Sciences51Science21Neuroscience23Strategy18Clinical Research16Lifesciences13Management Consulting9Medicine12Entrepreneurship9Biotechnology14
+4 more
Start-upsBusiness DevelopmentLeadershipProject ManagementFrom Nihal's professional profile.
Deals · 1
Antlia Bioscience, Inc.Board seat
via F-Prime Capital · filed Jun 2026 · $20M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Per SEC Form D filings.
Colleagues at F-Prime Capital
Abby Wagner
Senior Accountant at F-Prime Capital Partners
Abdul Abdirahman
Principal at F-Prime Capital Partners
Alex Pasteur
Partner at F-Prime Capital Partners
Alex Wong
Associate at F-Prime Capital Partners
Allan Galper
Vice President & Associate General Counsel at F-Prime Capital Partners
Allison MacLeod
Venture Partner at F-Prime Capital Partners
Amber Cai
Venture Partner at F-Prime Capital Partners
Andrew Bognanni
Director of Finance at F-Prime Capital Partners
Frequently asked questions
- Who is Nihal Sinha?
- Partner at F-Prime Capital Partners
- Where does Nihal Sinha work?
- Nihal Sinha is Partner at F-Prime Capital.
- What check size does Nihal Sinha write?
- Nihal Sinha typically writes checks of $100K – $10M.
- What boards does Nihal Sinha sit on?
- Nihal Sinha holds tracked board seats at Antlia Bioscience, Inc., CHARM Therapeutics.
- Where did Nihal Sinha go to school?
- Nihal Sinha studied at University of Cambridge (MB BChir, Medicine); Royal College of Physicians (MRCP, Medicine); University of Cambridge (MA, Physiology and Psychology).
Same school
Also attended University of Cambridge893
Stewart ButterfieldCo-founder of Slack and FlickrDemis HassabisCo-founder & CEO of Google DeepMindNiko BonatsosVerdict Capital founder and pre-consensus investor formerly at General CatalystGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesLeah von SiemensPartner at Manta Ray Ventures
+ 887 more
Also attended Harrow School22
Leroy LimExecutive Advisor at TCVAde OkuwogaInvestor at HeadlineJason PontinGeneral Partner at DCVC (Data Collective)Karl AlomarManaging Partner at M13Adrian LiFounder and Managing Partner at AC VenturesIbrahim AkhtarInvestment Associate at Apex Capital
+ 16 more
Also attended University of Oxford990
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageBrad GerstnerFounder & CEO of Altimeter CapitalGabriel PereyraCo-founder & President of HarveyDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index Ventures
+ 984 more
Shared employers
Also worked at Immutrin3
Also worked at Orchard Therapeutics3
Also worked at Fidelity Biosciences133
Peter SaperstonePartner at GreycroftRob KniazInvestor at Hoxton VenturesHelen ClementInvestor at IVP (Institutional Venture Partners)Adiam BerhaneAccounting Manager at QED InvestorsAubrie PaganoGeneral Partner, Managing Member at Corigin VenturesJoanna Skoler GilmanChief Marketing and Communications Officer at .406 Ventures
+ 127 more
Also worked at The Boston Consulting Group907
David SzeAdvisory Partner at GreylockDave MunichielloInvestor at GV (Google Ventures)Massimo PrelzInvestor at DN CapitalRasmus AreskougInvestor at DN CapitalRiccardo MontiOperating Advisor at P101 VenturesAntonio TurroniOperating Advisor at P101 Ventures
+ 901 more
























.png)





.webp)




















